argenx SE | ARGX - Sales Revenues

Stock Price
720.20
Daily Change
2.60 0.36%
Monthly
4.99%
Yearly
12.88%
Q1 Forecast
686.63

argenx SE reported $987.09M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
AstraZeneca USD 15.19B 733M Sep/2025
Galapagos EUR 65.3M 4.87M Sep/2025
Genmab DKK 5.86B 580M Jun/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.87B 20M Sep/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Qiagen NV USD 457.38M 6.06M Dec/2025
UCB EUR 3.49B 129M Jun/2025